Heartflow, Inc. will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 3, 2025. Their AI technology for coronary artery disease is backed by over 600 peer-reviewed publications and used by more than 1,400 institutions globally. The technology is based on a proprietary data pipeline with extensive clinical validation and seamless clinical integration. Heartflow aims to transform coronary artery disease into a manageable condition through early detection and accurate diagnosis. Learn more about their innovative approach at heartflow.com.

Read more at GlobeNewswire: Heartflow to Participate in the Piper Sandler 37th Annual